These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2514173)

  • 1. A novel multidrug resistance in cultured leukemia and lymphoma cells detected by a monoclonal antibody to 85-kDa protein, MRK20.
    Ohtsu T; Ishida Y; Tobinai K; Minato K; Hamada H; Ohkochi E; Tsuruo T; Shimoyama M
    Jpn J Cancer Res; 1989 Nov; 80(11):1133-40. PubMed ID: 2514173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
    Ishida Y; Ohtsu T; Hamada H; Sugimoto Y; Tobinai K; Minato K; Tsuruo T; Shimoyama M
    Jpn J Cancer Res; 1989 Oct; 80(10):1006-13. PubMed ID: 2575608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of multidrug resistant phenotype in leukemia and lymphoma by monoclonal antibodies].
    Shimoyama M; Ohtsu T; Ishida Y; Kuroki Y; Shimada Y; Tobinai K; Minato K; Hamada H; Tsuruo T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2863-70. PubMed ID: 2902832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cross and non-cross resistant anticancer agents to multidrug-resistant cultured cells from hematologic malignancies].
    Shimoyama M; Ishida Y; Ohtsu T; Shimada Y; Tobinai K; Minato K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1273-9. PubMed ID: 2730025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and tissue distribution of MRK20 murine monoclonal antibody-defined 85-kDa protein in adriamycin-resistant cancer cell lines.
    Sugawara I; Ohkochi E; Hamada H; Tsuruo T; Mori S
    Jpn J Cancer Res; 1988 Oct; 79(10):1101-10. PubMed ID: 2904427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of multidrug resistant cells in human malignant diseases by monoclonal antibodies and strategy to eradicate resistant malignant cells].
    Shimoyama M; Ohtsu T; Ishida Y; Shimada Y; Tobinai K; Minato K; Tsuruo T
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):611-6. PubMed ID: 2565103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18.
    Sugimoto Y; Okochi E; Hamada H; Oh-hara T; Tsuruo T
    Biochem Biophys Res Commun; 1990 Jun; 169(2):686-91. PubMed ID: 1972622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
    Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression.
    Harker WG; Slade DL; Dalton WS; Meltzer PS; Trent JM
    Cancer Res; 1989 Aug; 49(16):4542-9. PubMed ID: 2568172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
    Ishida Y; Shimada Y; Shimoyama M
    Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression of P-glycoprotein and 85 kD protein as assessed by flow cytometry and immunocytochemistry in leukemias and malignant lymphomas.
    Umeda Y; Tsuruo T; Mori S; Arimori S; Sugawara I
    Tokai J Exp Clin Med; 1990 May; 15(2-3):179-87. PubMed ID: 1983371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M; Komeshima N; Naito M; Isoe T; Otake N; Tsuruo T
    Cancer Res; 1991 Jan; 51(1):157-61. PubMed ID: 1988080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks.
    Horichi N; Tapiero H; Sugimoto Y; Bungo M; Nishiyama M; Fourcade A; Lampidis TJ; Kasahara K; Sasaki Y; Takahashi T
    Cancer Res; 1990 Aug; 50(15):4698-701. PubMed ID: 2164445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a K562 multidrug-resistant cell line.
    Yanovich S; Hall RE; Gewirtz DA
    Cancer Res; 1989 Aug; 49(16):4499-503. PubMed ID: 2568171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Restorative effect of quercetin on subcellular distribution of daunorubicin in multidrug resistant leukemia cell lines K562/ADM and HL-60/ADM].
    Cai X; Chen FY; Han JY; Gu CH; Zhong H; Ouyang RR
    Ai Zheng; 2004 Dec; 23(12):1611-5. PubMed ID: 15601547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
    Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
    Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.